CBG and It’s Potential to Treat TBI/Neurological Disorders
Authored by Anthony Robison Cannabigerol (CBG) is a non-psychoactive cannabinoid found in the cannabis plant that has garnered attention for its potential neuroprotective properties. Emerging research suggests that CBG may offer therapeutic benefits for various neurodegenerative diseases through several mechanisms: Antioxidant Effects Oxidative stress plays a significant role in the progression of neurodegenerative diseases. CBG has demonstrated antioxidant properties that help neutralize harmful free radicals, thereby protecting neurons from oxidative damage. A study comparing the antioxidant effects of cannabidiol (CBD) and CBG found that both cannabinoids effectively reduced oxidative stress in rat astrocyte cells exposed to hydrogen peroxide, suggesting potential neuroprotective benefits. Anti-inflammatory Actions Chronic neuroinflammation is a common feature of many neurodegenerative conditions. CBG appears to modulate inflammatory responses by influencing cytokine production...